Citigroup

Citigroup’s Enliven Therapeutics ELVN Stock Holding History

Citigroup’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$576K	Sell	14,701 -3,788	-20%	-$105K	﹤0.01%	3460
2025 Q4	$285K	Buy	18,489 +6,743	+57%	+$134K	﹤0.01%	3836
2025 Q3	$240K	Sell	11,746 -6,393	-35%	-$129K	﹤0.01%	3917
2025 Q2	$364K	Sell	18,139 -12,700	-41%	-$240K	﹤0.01%	3799
2025 Q1	$607K	Sell	30,839 -2,709	-8%	-$58.3K	﹤0.01%	3574
2024 Q4	$755K	Buy	33,548 +4,650	+16%	+$121K	﹤0.01%	3564
2024 Q3	$738K	Buy	28,898 +18,296	+173%	+$424K	﹤0.01%	3488
2024 Q2	$248K	Buy	10,602 +2,769	+35%	+$58.3K	﹤0.01%	3783
2024 Q1	$138K	Buy	7,833 +427	+6%	+$6.55K	﹤0.01%	4164
2023 Q4	$102K	Buy	7,406 +4,059	+121%	+$49.7K	﹤0.01%	4192
2023 Q3	$45.7K	Sell	3,347 -7,476	-69%	-$126K	﹤0.01%	4172
2023 Q2	$221K	Sell	10,823 -440	-4%	-$8.89K	﹤0.01%	3847
2023 Q1	$247K	Buy	+11,263	New	+$229K	﹤0.01%	3602
2021 Q2	–	Sell	-127	Closed	-$4K	–	6192
2021 Q1	$4K	Sell	127 -227	-64%	-$11.5K	﹤0.01%	5936
2020 Q4	$31K	Buy	354 +294	+490%	+$24.7K	﹤0.01%	6366
2020 Q3	$5K	Sell	60 -108	-64%	-$9.74K	﹤0.01%	6996
2020 Q2	$19K	Buy	+168	New	+$18.8K	﹤0.01%	6650

Other funds holding ELVN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return